ArticleOncoimmunology

Enhancing the immune stimulatory effects of cetuximab therapy through TLR3 signalling in Epstein-Barr virus (EBV) positive nasopharyngeal carcinoma.

Louise Soo Yee Tan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.